Furthermore, combination of HDAC6 inhibitor with a PI3K inhibitor caused substantial tumor growth inhibition in vivo compared with either treatment alone, also detectable by Ki-67 immunostaining and 18F-FLT positron emission tomography (PET). Here, PIK3CA is linked to neoplasm.